Kim Wolff

Summary

Affiliation: King's College London
Country: UK

Publications

  1. ncbi request reprint A review of biological indicators of illicit drug use, practical considerations and clinical usefulness
    K Wolff
    National Addiction Centre, Institute of Psychiatry, Kings College London, UK
    Addiction 94:1279-98. 1999
  2. ncbi request reprint Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population
    Kim Wolff
    National Addiction Centre, Institute of Psychiatry, King s College London, 4 Windsor Walk, London SE5 8AF, UK
    J Psychopharmacol 20:400-10. 2006
  3. ncbi request reprint Ketamine : from medicine to misuse
    Kim Wolff
    King s College London National Addiction Centre, Institute of Psychiatry, London, England
    CNS Drugs 20:199-218. 2006
  4. ncbi request reprint Changes to methadone clearance during pregnancy
    Kim Wolff
    National Addiction Centre, Division of Psychological Medicine, Institute of Psychiatry, King s College London, Addiction Sciences Building, 4, Windsor Walk, London, SE5 8AF, UK
    Eur J Clin Pharmacol 61:763-8. 2005
  5. doi request reprint Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT
    Katherine J Aitchison
    MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King s College London, London, UK
    J Psychopharmacol 26:408-18. 2012
  6. ncbi request reprint Drug testing by chemical analysis of fingerprint deposits from methadone-maintained opioid dependent patients using UPLC-MS/MS
    Shana Jacob
    Pharmaceutical Sciences Research Division, King s College London, London SE1 9NH, UK
    Drug Metab Lett 2:245-7. 2008
  7. ncbi request reprint Patterns of adherence to oral methadone: implications for prescribers
    Michael Haskew
    South Camden Drug Service, Camden and Islington Mental Health and Social Care NHS Trust, London, UK
    J Subst Abuse Treat 35:109-15. 2008
  8. doi request reprint Follow-up of provision of inpatient treatment for UK Healthcare Professionals with alcohol dependence: snapshot of a pilot specialist National Health Service
    Samantha R Gross
    National Addiction Centre, Institute of Psychiatry, Kings College, London, UK
    Subst Use Misuse 44:1916-25. 2009
  9. ncbi request reprint Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice
    K J Aitchison
    Section of Clinical Pharmacology, Institute of Psychiatry, London, UK
    J Psychopharmacol 14:353-9. 2000
  10. doi request reprint Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
    Kim Wolff
    King s College London, Institute of Psychiatry, Addiction Department, London, UK
    J Psychopharmacol 26:419-28. 2012

Detail Information

Publications16

  1. ncbi request reprint A review of biological indicators of illicit drug use, practical considerations and clinical usefulness
    K Wolff
    National Addiction Centre, Institute of Psychiatry, Kings College London, UK
    Addiction 94:1279-98. 1999
    ..To examine a range of biological indicators of illicit drug use, including blood, urine, hair and saliva, addressing both technological and practical issues relating to their application and interpretation...
  2. ncbi request reprint Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population
    Kim Wolff
    National Addiction Centre, Institute of Psychiatry, King s College London, 4 Windsor Walk, London SE5 8AF, UK
    J Psychopharmacol 20:400-10. 2006
    ..This report demonstrates SIADH in ecstasy-using "clubbers", which has important clinical implications...
  3. ncbi request reprint Ketamine : from medicine to misuse
    Kim Wolff
    King s College London National Addiction Centre, Institute of Psychiatry, London, England
    CNS Drugs 20:199-218. 2006
    ..The potential of ketamine as a novel clinical and research tool is matched by its abuse potential outside medical settings...
  4. ncbi request reprint Changes to methadone clearance during pregnancy
    Kim Wolff
    National Addiction Centre, Division of Psychological Medicine, Institute of Psychiatry, King s College London, Addiction Sciences Building, 4, Windsor Walk, London, SE5 8AF, UK
    Eur J Clin Pharmacol 61:763-8. 2005
    ..A secondary objective was to evaluate the outcome of pregnancy...
  5. doi request reprint Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT
    Katherine J Aitchison
    MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King s College London, London, UK
    J Psychopharmacol 26:408-18. 2012
    ....
  6. ncbi request reprint Drug testing by chemical analysis of fingerprint deposits from methadone-maintained opioid dependent patients using UPLC-MS/MS
    Shana Jacob
    Pharmaceutical Sciences Research Division, King s College London, London SE1 9NH, UK
    Drug Metab Lett 2:245-7. 2008
    ..Chemical analysis of fingerprint deposits from methadone-maintained opioid-dependent patients by UPLC-MS/MS show detectable levels of methadone and its metabolite, EDDP, demonstrating intake of the drug...
  7. ncbi request reprint Patterns of adherence to oral methadone: implications for prescribers
    Michael Haskew
    South Camden Drug Service, Camden and Islington Mental Health and Social Care NHS Trust, London, UK
    J Subst Abuse Treat 35:109-15. 2008
    ..New approaches to encouraging adherence, including a more systematic monitoring of adherence to improve the effectiveness of methadone programs, are needed...
  8. doi request reprint Follow-up of provision of inpatient treatment for UK Healthcare Professionals with alcohol dependence: snapshot of a pilot specialist National Health Service
    Samantha R Gross
    National Addiction Centre, Institute of Psychiatry, Kings College, London, UK
    Subst Use Misuse 44:1916-25. 2009
    ..There is a need for supported and dedicated services for this group within the UK National Health Service. The study's limitations are noted...
  9. ncbi request reprint Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice
    K J Aitchison
    Section of Clinical Pharmacology, Institute of Psychiatry, London, UK
    J Psychopharmacol 14:353-9. 2000
    ..Our data also indicate that CYP1A2 poor metabolizers might be more susceptible than extensive metabolizers to dose-related adverse effects of clozapine, such as sedation, myoclonus and seizures...
  10. doi request reprint Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
    Kim Wolff
    King s College London, Institute of Psychiatry, Addiction Department, London, UK
    J Psychopharmacol 26:419-28. 2012
    ....
  11. doi request reprint Hydrophilic stationary phases: a practical approach for the co-analysis of compounds with varying polarity in biological matrices
    Edward Goucher
    Department of Forensic Science and Drug Monitoring, Pharmaceutical Science Research Division, King s College London, London, UK
    J Sep Sci 33:955-65. 2010
    ..LC-MS/MS analysis of creatinine and drug compounds together offers considerable advantages over traditional approaches that necessitate the quantification of creatinine using spectrophotometric approaches...
  12. ncbi request reprint 4-MTA: a new synthetic drug on the dance scene
    Adam R Winstock
    National Addiction Centre, Institute of Psychiatry, Addiction Sciences Building, 4 Windsor Walk, SE5 8AF, London, UK
    Drug Alcohol Depend 67:111-5. 2002
    ..Responses to the effects of the drug were mixed, although about a quarter of those who believed that they had tried 4-MTA thought that they would use it again...
  13. ncbi request reprint Characterization of methadone overdose: clinical considerations and the scientific evidence
    Kim Wolff
    National Addiction Centre, London, United Kingdom
    Ther Drug Monit 24:457-70. 2002
    ..Indeed the key issue with methadone that sets it apart from other opioids is its potential for delayed toxicity. Consequently steps should be taken to disseminate the salient facts to all those who come into contact with the drug...
  14. ncbi request reprint Ecstasy pill testing: harm minimization gone too far?
    A R Winstock
    National Addiction Centre, Institute of Psychiatry, Kings College London, UK
    Addiction 96:1139-48. 2001
    ..At best it gives an artificial 'shine of safety' to a group of diverse drugs that remain both illicit and potentially harmful. Other simpler harm reduction mechanisms are likely to be more effective...
  15. ncbi request reprint Excessive alcohol consumption is associated with reduced quality of life among methadone patients
    Richard Senbanjo
    East Kent Community Drug Service, KCA, Ashford, Kent, UK
    Addiction 102:257-63. 2007
    ..To evaluate the impact of excessive alcohol consumption on the health-related quality of life of patients receiving methadone treatment for opioid dependence...
  16. ncbi request reprint Using focus group interviews to understand staff perceptions from training in the therapeutic community model
    Anna Tsiboukli
    Hellenic Open University, Athens, Greece
    J Drug Educ 33:143-57. 2003
    ..The article concludes that gaining information on people's own perceptions and experiences from the training process can contribute significantly to program improvement...